Catalan (Catherine) Carico (Katalin Kariko)

Born January 17, 1955 in Salnok, Hungary (Szolnok, Hungary), but grew up in Kisújszállás. Her father was a butcher and mother worked an accountant.

Enrolled at Móricz Zsigmond Grammar School

1973, enrolled at the University of Szeged, friends at school called her Katie (Kati).

In 1978, after graduating, enrolled a doctorate at the Szeged Biological Research Center, part of the university.

1980 married Bera Francia, who later had a child together named Susan (Zsuzzanna “Susan” Francia), whom Susan was later a two-time Olympic gold medallist and five-time world champion.

1982 Ph.D.

In 1985, Catalin and her husband, along with their children, moved to Philadelphia, U.S., and Catalin attended Temple University, where Calati Focus's research went to RNA from the beginning.

He moved to the University of Pennsylvania in 1989 to work at the University of Pennsylvania. He received a small position as a research assistant for Dr. Dr. Elliot Barnathan, who collaborated on how to bring mRNA into cells in a cell without being destroyed by immunity and inducing cells to create the desired protein. In the early stages of the experiment, they tried to make cells produce a protein called urokinase receptor, which their efforts struggled. Success in the end

Later, Catalan and Dr. Elliott then tried to get mRNA to develop blood cell efficacy to aid coronary artery surgery.

Later on, Dr. Elliott moved away from the university. Catalan, which remained at Jan. Pennsylvania has shifted to working with Dr. Nassar. Dr. Langer, who heads the neurosurgery department, where Dr. Langer said, “Dr. Langer,” who heads neurosurgery. Langer encouraged Catalin to find ways to use mRNA to treat patients who underwent brain surgery but suffered cerebral clotting. Langer had the idea that she wanted to use mRNA techniques to encourage blood cells to create nitric oxide, which helps expand blood vessels. But their experiment failed so many times, until Dr. Langer said, “I think it's a lot of time.” Langer moved away from campus.

1998 Catalin met with Dr. Dr Drew Weissman, who took over work at the University of Pennsylvania to conduct research to develop HIV vaccines, which at that early stage, said Dr. Drew Weissman. Weisman had tried to develop a DNA vaccine, but was unsuccessful until after reading Catalin's research, Dr. Wishman said. Weisman was so interested in using mRNA.

2005 University of Pennsylvania, Catalin and Dr. Weisman patented the use of manah mRNA and could direct cells to create the desired protein.

Which, later, M. Pelsilvania sold the patent to CellScript LLC U.S., Moderna U.S., and BionTech in Germany.

2006 founded RNaX together with Dr. Weisman

The small company BionTech was founded in Germany by two husband-wife doctors Ugur Sahin and Ozlem Tureci. They were both Turkish citizens who emigrated to Germany.

They were supported by BionTech to develop bore vaccines for cancer and infectious diseases. BionTech is researching many mRNA vaccines in various diseases, such as Flu, Zika vaccine. (Zika)

January 2020, Chinese authorities have decoded the genome of the SARS-COV-2 virus and published online for researchers around the world to develop drugs or vaccines against covids.

Catalin and BionTech took a few hours to design the anti-covid-19 vaccine, aiming to encourage cells in the human body to create a spike protein like the thorns of the coronavirus. BionTech then contacted Pfizer to support the research.

And in a few months to create a real vaccine, it also requires the cooperation of many scientists in different areas.

December 18, Catalin and Dr. Weisman received the Pfizer/ BionTech Covid19 vaccine at the University of Pennsylvania.

2021 receives the Rosentiel Award in conjunction with Dr. Weisman